Lake Street Maintains Buy on ClearPoint Neuro, Lowers Price Target to $15
Portfolio Pulse from jenniferd'souza@benzinga.com
Lake Street analyst Frank Takkinen has maintained a 'Buy' rating on ClearPoint Neuro (NASDAQ:CLPT), but lowered the price target from $22 to $15.
August 09, 2023 | 2:23 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
ClearPoint Neuro's price target has been lowered from $22 to $15 by Lake Street, though the 'Buy' rating is maintained.
The lowering of the price target by Lake Street could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the company, which could counterbalance the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100